Safety outcomes of salbutamol: A systematic review and meta-analysis.

Authors:
Ma LH; Jia L; Bai L.

Journal:
Clin Respir J

Publication Year: 2023

DOI:
10.1111/crj.13711

PMCID:
PMC10730473

PMID:
37844914

Journal Information

Full Title: Clin Respir J

Abbreviation: Clin Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the detail of literature search strategy was shown in data s1 2 2 the following data were extracted from each study that met inclusion criteria: the first author's name publication year country number of patients in the salbutamol cohort mean age indication formulation of salbutamol numbers of patients with total aes severe aes treatment discontinuation and specific aes (including tremor palpitations or tachycardia headache nervousness anxiety cough dyspnoea nausea and vomiting) in the salbutamol cohort and incidence of above aes in the salbutamol cohort.; data s1."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT No conflict of interest was associated with this work."

Evidence found in paper:

"This work was supported by the Technology and Innovation Project of Xinjiang Uygur Autonomous Region People's Hospital (No. 20180311) and the Natural Science Foundation of Xinjiang Uygur Autonomous Region (No. 2021D01A136)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025